AAAAAA
Results:
1-13
|
Results: 13
Authors:
Marcocci, C
Bartalena, L
Tanda, ML
Manetti, L
Dell'Unto, E
Rocchi, R
Barbesino, G
Mazzi, B
Bartolomei, MP
Lepri, P
Cartei, F
Nardi, M
Pinchera, A
Citation: C. Marcocci et al., Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: Results of a prospective, single-blind, randomized study, J CLIN END, 86(8), 2001, pp. 3562-3567
Authors:
Tomer, Y
Greenberg, DA
Barbesino, G
Concepcion, E
Davies, TF
Citation: Y. Tomer et al., CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production, J CLIN END, 86(4), 2001, pp. 1687-1693
Authors:
Cetani, F
Barbesino, G
Borsari, S
Pardi, E
Cianferotti, L
Pinchera, A
Marcocci, C
Citation: F. Cetani et al., A novel mutation of the autoimmune regulator gene in an Italian kindred with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy, acting in a dominant fashion and strongly cosegregating with hypothyroid autoimmunethyroiditis, J CLIN END, 86(10), 2001, pp. 4747-4752
Authors:
Villanueva, R
Inzerillo, AM
Tomer, Y
Barbesino, G
Meltzer, M
Concepcion, ES
Greenberg, DA
MacLaren, N
Sun, ZS
Zhang, DM
Tucci, S
Davies, TF
Citation: R. Villanueva et al., Limited genetic susceptibility to severe Graves' ophthalmopathy: No role for CTLA-4 but evidence for an environmental etiology, THYROID, 10(9), 2000, pp. 791-798
Authors:
Marino, M
Barbesino, G
Pinchera, A
Manetti, L
Ricciardi, R
Rossi, B
Muratorio, A
Braverman, LE
Mariotti, S
Chiovato, L
Citation: M. Marino et al., Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis, THYROID, 10(9), 2000, pp. 799-802
Authors:
Barbesino, G
Chiovato, L
Citation: G. Barbesino et L. Chiovato, The genetics of Hashimoto's disease, END METAB C, 29(2), 2000, pp. 357
Authors:
Bartalena, L
Manetti, L
Tanda, ML
Dell'Unto, E
Mazzi, B
Rocchi, R
Barbesino, G
Pinchera, A
Marcocci, C
Citation: L. Bartalena et al., Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoids, CLIN ENDOCR, 52(5), 2000, pp. 647-651
Authors:
Marcocci, C
Bartalena, L
Tanda, ML
Manetti, L
Dell'Unto, E
Mazzi, B
Rocchi, R
Barbesino, G
Pinchera, A
Citation: C. Marcocci et al., Graves' ophthalmopathy and I-131 therapy, Q J NUCL M, 43(4), 1999, pp. 307-312
Authors:
Marino, M
Latrofa, F
Barbesino, G
Chiovato, L
Citation: M. Marino et al., Pathogenetic and clinical aspects of autoimmune thyroiditis, EXP CL E D, 107, 1999, pp. S79-S83
Authors:
Mariotti, S
Barbesino, G
Chiovato, L
Marino, M
Pinchera, A
Zuliani, G
Mezzetti, A
Fellin, R
Citation: S. Mariotti et al., Circulating thyroid autoantibodies in a sample of Italian octo-nonagenarians: Relationship to age, sex, disability, and lipid profile, AGING-CLIN, 11(6), 1999, pp. 362-366
Authors:
Tomer, Y
Barbesino, G
Greenberg, DA
Concepcion, E
Davies, TF
Citation: Y. Tomer et al., Mapping the major susceptibility loci for familial Graves' and Hashimoto'sdiseases: Evidence for genetic heterogeneity and gene interactions, J CLIN END, 84(12), 1999, pp. 4656-4664
Authors:
Tomer, Y
Barbesino, G
Greenberg, DA
Concepcion, E
Davies, TF
Citation: Y. Tomer et al., Linkage analysis of candidate genes in autoimmune thyroid disease. III. Detailed analysis of chromosome 14 localizes Graves' disease-1 (GD-1) close to multinodular goiter-1 (MNG-1), J CLIN END, 83(12), 1998, pp. 4321-4327
Authors:
Tomer, Y
Barbesino, G
Greenberg, DA
Concepcion, E
Davies, TF
Citation: Y. Tomer et al., A new Graves disease-susceptibility locus maps to chromosome 20q11.2, AM J HU GEN, 63(6), 1998, pp. 1749-1756
Risultati:
1-13
|